Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Bander

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Urology|July 21, 2009
Editorial commentNeil H Bander
Nature Clinical Practice. Urology|April 12, 2006
Technology insight: monoclonal antibody imaging of prostate cancerNeil H Bander
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Antibody-drug conjugate target selection: critical factorsNeil H Bander
BJU International|April 20, 2007
Active and passive immunotherapy: vaccines and antibodiesEgbert Oosterwijk, Chaitanya Divgi, Neil H Bander
Annual Review of Medicine|January 29, 2024
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate CancerLena M Unterrainer, Jeremie Calais, Neil H Bander
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Antibody-drug conjugate technology development for hematologic disordersNeil H Bander, Myron S Czuczman, Anas Younes
Journal of Visualized Experiments : Jove|June 5, 2014
In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cellsGunjan Gakhar, Neil H Bander, David M Nanus
European Urology Focus|March 2, 2021
Emerging Prostate-specific Membrane Antigen-based Therapeutics: Small Molecules, Antibodies, and BeyondJones T Nauseef, Neil H Bander, Scott T Tagawa
JAMA Oncology|September 16, 2021
Prostate-Specific Membrane Antigen Positron Emission Tomography and the New Algorithm for Patients With Prostate Cancer Prior to ProstatectomyJoseph R Osborne, Neil H Bander, Scott T Tagawa
Biomedical Microdevices|June 29, 2013
Enrichment of prostate cancer cells from blood cells with a hybrid dielectrophoresis and immunocapture microfluidic systemChao Huang, He Liu, Neil H Bander, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Urology|July 21, 2009
Editorial commentNeil H Bander
Nature Clinical Practice. Urology|April 12, 2006
Technology insight: monoclonal antibody imaging of prostate cancerNeil H Bander
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Antibody-drug conjugate target selection: critical factorsNeil H Bander
BJU International|April 20, 2007
Active and passive immunotherapy: vaccines and antibodiesEgbert Oosterwijk, Chaitanya Divgi, Neil H Bander
Annual Review of Medicine|January 29, 2024
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate CancerLena M Unterrainer, Jeremie Calais, Neil H Bander
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Antibody-drug conjugate technology development for hematologic disordersNeil H Bander, Myron S Czuczman, Anas Younes
Journal of Visualized Experiments : Jove|June 5, 2014
In vitro method to observe E-selectin-mediated interactions between prostate circulating tumor cells derived from patients and human endothelial cellsGunjan Gakhar, Neil H Bander, David M Nanus
European Urology Focus|March 2, 2021
Emerging Prostate-specific Membrane Antigen-based Therapeutics: Small Molecules, Antibodies, and BeyondJones T Nauseef, Neil H Bander, Scott T Tagawa
JAMA Oncology|September 16, 2021
Prostate-Specific Membrane Antigen Positron Emission Tomography and the New Algorithm for Patients With Prostate Cancer Prior to ProstatectomyJoseph R Osborne, Neil H Bander, Scott T Tagawa
Biomedical Microdevices|June 29, 2013
Enrichment of prostate cancer cells from blood cells with a hybrid dielectrophoresis and immunocapture microfluidic systemChao Huang, He Liu, Neil H Bander, et al.
Pageof 9